$152.28
0.06% yesterday
NYSE, Jun 25, 10:10 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock News

Positive
Seeking Alpha
2 days ago
Johnson & Johnson is a stable, dividend-growth powerhouse with 62 years of increases and a 3.44% forward yield, ideal for conservative, long-term investors. Despite recent legal headwinds and flat core growth, JNJ remains undervalued, trading at a significant discount to the sector median P/E. Talc litigation overhang has depressed sentiment, but 95% of cases are resolved and market recovery su...
Positive
Seeking Alpha
2 days ago
The Dividend Income Accelerator Portfolio balances income, growth, and capital appreciation, now enhanced by the global diversification from Allianz and LVMH. We focus on financially healthy companies with sustainable dividends and strong competitive advantages, optimizing risk-reward through sector and geographic diversification. The portfolio's Weighted Average Dividend Yield [FWD] of 4.05% a...
Positive
Seeking Alpha
2 days ago
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a collective 2025 growth rate of 5.19%, despite some downward earnings revisions. Seventeen Dividend Kings appear undervalued and offer long-term annualized expected returns of at least 10%, based on ...
Positive
The Motley Fool
2 days ago
When companies deploy artificial intelligence (AI) to streamline operations, the results can be staggering. Microsoft (MSFT 1.88%) is using AI-powered code-completion tools to help developers write code 55% faster.
Positive
Seeking Alpha
2 days ago
Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. I highlight two such names that are undervalued compared to historical norms while paying strong and well-covered dividends. Both carry moat-worthy attributes and provide economically essential products and services that make them recession resilient.
Neutral
PRNewsWire
3 days ago
The ITC compared all published Phase 3 data of these treatments, leveraging longitudinal results, and findings reinforce the importance of consistent, sustained disease control in managing a chronic autoantibody disease like gMG IMAAVY, an FcRn blocker, received U.S. FDA approval earlier this year for the broadest population of individuals living with gMG, including anti-AChR and anti-MuSK anti...
Positive
Seeking Alpha
6 days ago
I added Allianz and LVMH to The Dividend Income Accelerator Portfolio for their blend of dividend yield, growth, and financial strength. Both companies offer strong dividend growth potential—Allianz with a Dividend Yield [FWD] of 4.31%, and LVMH with a Dividend Yield [FWD] of 3.19%—plus robust long-term growth prospects. These additions improve our portfolio's potential risk-adjusted returns, v...
Neutral
Business Wire
8 days ago
BOSTON--(BUSINESS WIRE)--A Suffolk County jury has awarded $8 million in favor of Janice Paluzzi, a Massachusetts woman who developed mesothelioma after decades of using Johnson & Johnson's (NYSE:JNJ) talcum powder products. The jury found the pharmaceutical giant liable for negligence and breach of warranty, concluding that the company's asbestos-contaminated talcum powder products caused Palu...
Show more news

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today